Vous n'êtes pas identifié (connexion)

Centre de recherche

JEUDI 04 MAI

Dr Nicholas Brousseau et Dre Marie-France Beaudet, Direction de la Santé publique

Séminaire

Les oreillons; toujours d'actualité en 2017

Calendrier >

BOTTIN

André-Guy Martin

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Oncologie
Adresse(s)
Hôtel-Dieu de Québec
11 Côte du Palais, Bureau 3342
Québec (Québec)
CANADA G1R 2J6

Téléphone(s)
+1 418-691-5264
Télécopieur(s)
Courriel(s)
andre-guy.martin@mail.chudequebec.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Miksys N, Vigneault E, Martin AG, Beaulieu L, Thomson RM. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy. International journal of radiation oncology, biology, physics ,  2017. 97: 606-615
Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L. Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy. Cureus,  2016. Epub
Vigneault E, Savard J, Ivers H, Savard MH, Fradet V, Despres P, Foster W, Martin AG. Validation of a French-Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC). International journal of radiation oncology, biology, physics ,  2016. 96: E531-E532
Vigneault E, Mbodji K, Beaudet ME, Despres P, Lavallee MC, Martin AG, Foster W, Aubin S, Beaulieu L. Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. Epub
Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L. Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study. Brachytherapy,  2016. Epub
Gaudet M, Vigneault E, Foster W, Meyer F, Martin AG. Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. 118: 141-7
Smith GD, Pickles T, Crook J, Martin AG, Vigneault E, Cury FL, Morris J, Catton C, Lukka H, Warner A, Yang Y, Rodrigues G. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis. International journal of radiation oncology, biology, physics ,  2015. 91: 505-16
Martin AG, Lacroix F, Niedermayr T, Nguyen PL. Genitourinary Brachytherapy (Chapter 4) In: Devlin PM, Stewart AJ, Cormack RA, Holloway CL, eds.  Brachytherapy : applications and techniques New York, NY: Demos Medical, 2015. p..
Warner A, Pickles T, Crook J, Martin AG, Souhami L, Catton C, Lukka H, Rodrigues G. Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer. Cureus,  2015. 7: e276
Collins Fekete CA, Plamondon M, Martin AG, Vigneault E, Verhaegen F, Beaulieu L. Calcifications in low-dose rate prostate seed brachytherapy treatment: post-planning dosimetry and predictive factors. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2015. 114: 339-44
© 2017 Tous droits réservés Centre de recherche du CHU de Québec